We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Synthetic Bone Material Shows Promise in Spinal Fusion

By HospiMedica staff writers
Posted on 20 May 2002
Preliminary results from three ongoing studies in Europe and the United States show that patients who received a synthetic bone void filler material called Vitoss in a spinal fusion procedure have progressed successfully to a solid fusion at the three-to-six month followup. More...


The study involved 95 patients who received Vitoss as an autograft extender or as an allograft extender. Unlike donor bone materials from cadavers, Vitoss poses no risk of biocontamination, infection, or rejection. Vitoss is a highly porous scaffold composed of nanometer-sized calcium phosphate particles with 90% interconnecting porosity that are designed to replicate the characteristics of human cancellous bone and allow for resorption, cell seeding, and ingrowth of host bone. Use of Vitoss can avoid the need to harvest bone from other areas in the body or use cadaver bone materials, says Orthovita, Inc. (Malvern, PA, USA), which developed the synthetic bone material.

"While autograft remains the gold standard for lumbar spinal fusions, these studies indicate that Vitoss can offer significant advantages as an extender to autograft or allograft, and in some cases can even be used alone successfully,” said Raymond Linovitz, MD, a spine surgeon in San Diego (CA, USA) and a lead investigator on one of the studies.




Related Links:
Orthovita

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.